Postoperative Pain Management: From Pathophysiology to Practice

Part 1: The Pathophysiology of Postoperative Pain (Dr. Jyotsna Shah)

Why is postoperative pain still a major medical challenge?

Poorly managed postoperative pain can delay recovery and discharge,
and prevent patients from participating in rehabilitation programs.
Surveys from 1993, 2003, and 2012 in the US, and a European survey of over 700 hospitals,
consistently show that postoperative pain is common and remains undertreated.
The latest survey from the NIH around 2016 found that at least 80% of patients in the US suffered from postoperative pain,
and 50% received inadequate pain relief.
Reasons identified include the absence of documentation and a lack of written protocols.

What is the official definition of pain?

In 1979, the International Association for the Study of Pain (IASP) defined pain as "an unpleasant sensory and emotional experience associated with actual or potential tissue damage, or described in terms of such damage."
In July 2020, the definition was revised to: "an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage."
This new definition includes six key notes and the etymology of the word "pain" for further context,
emphasizing that anything resembling tissue damage should also be considered.

How are acute pain and chronic persistent postsurgical pain (CPSP) defined?

Acute pain is a subjective sensation in response to objectifiable signals,
the cyclical adjunct of a protective reflex.
It is an easily identifiable event (surgery), usually self-limiting, and acts as a warning of ongoing damage.
If untreated, acute pain may progress to chronic pain.
The IASP defines chronic persistent post-operative pain as clinical discomfort lasting more than 2 months post-surgery, without other causes like chronic infection or pre-existing pain.
However, the International Classification of Diseases (ICD-11) states this persistent pain lasts at least 3 months post-surgery,
as healing times differ, and it is a continuum of acute postoperative pain.

What are the key concepts in the neurobiology of acute pain?

The primary goal of acute pain pathways is to eliminate further pain, operating at three levels:

Sensory (discriminatory): Identifies the location and intensity.
Motivational (affective): The emotional response.
Cognitive (evaluative): Interprets the pain based on context.

Nociceptors (free nerve endings) at the incision site respond to chemical, mechanical, or thermal stimuli.
They have a high response threshold with persistent discharge to suprathreshold stimuli.
These signals travel via A-delta (thin, myelinated) and C (polymodal, unmyelinated) fibers to synapse in the dorsal horn of the spinal cord.
From there, the signal crosses to the opposite side and ascends via the spinothalamic tract to the cortex.
Simultaneously, anti-nociceptive pathways work to modulate the pain stimulus.

What is peripheral sensitization, and what is the "sensitizing soup"?

Acute postoperative pain is a pathophysiological state involving both peripheral and central sensitization.
Peripheral sensitization occurs at the nociceptor level due to surgical trauma, inflammation, and nerve injury.
This releases a "sensitizing soup" of mediators, including:

Hydrogen ions
Noradrenaline
Bradykinin
Histamine
Potassium
Prostaglandins
Cytokines
Substance P
Leukotrienes
Nerve Growth Factor (NGF): Now understood to play a very important role.
Neuropeptides

This soup causes transduction sensitivity, turning high-threshold nociceptors into low-threshold ones, leading to primary hyperalgesia (pain at the site of injury).
The degradation of mast cells and release of mediators can also cause secondary hyperalgesia,
where the normal area adjacent to the incision also becomes painful.

What is central sensitization and its role in pain?

Central sensitization occurs at the level of the dorsal horn neurons.
A barrage of nociceptive input causes an activity-dependent increase in their excitability.
This modifies responsiveness, so low-threshold mechanoreceptors are altered, and previously non-painful stimuli become painful.
A key process is the "wind-up" phenomenon. The main neurotransmitter is glutamate, which acts on AMPA receptors for acute pain.
Prolonged AMPA receptor stimulation primes the adjacent NMDA receptors by removing a magnesium block.
This allows calcium to enter, activating protein kinases and leading to neural plasticity and remodeling,
which are factors that can lead to the transition to chronic pain.

How can the transition from acute to chronic pain occur?

The transition is a complex phenomenon involving biological, psychological, and socio-environmental factors.
If at the time of surgery, the nociceptive and anti-nociceptive pathways are balanced, recovery is fast.
If the anti-nociceptive pathway is depressed, causing disequilibrium, it takes longer to recover.
This can lead to latent pain sensitization.
Factors influencing this include:

The initial nociceptive insult may sensitize individuals long-term.
Epigenetic changes.
Inability to recruit endogenous pain inhibitory systems.
Intensity of postoperative pain.
Nerve injury or duration of surgery.

Part 2: Recent Trends in Postoperative Pain Management (Dr. Pradeep Jain)

Why is effective postoperative pain management so important?

A surgical incision causes a sympathetic stimulation and a stress response.
This leads to neuroendocrine and metabolic changes, catabolism, negative protein balance, organ system dysfunction, hyperglycemia, hypercoagulability, hyperalgesia, allodynia, immunosuppression, and psychological dysfunction.
Effective management aims to provide safe, continuous analgesia free from side effects,
which improves quality of life, facilitates rapid recovery, reduces morbidity, and allows early discharge.

What are the recent advances and goals in the field?

Recent advances are based on a better understanding of molecular mechanisms and include new pharmaceutical products,
novel routes and modes of delivery, and improved organizational aspects.
The goals have shifted towards a multimodal approach, which is now the gold standard for perioperative analgesic care.

What is multimodal analgesia?

Multimodal analgesia is an approach to pain management that uses two or more drugs that act at different sites in the pain pathway via different routes.
The goal is to achieve reduced doses of individual drugs, improved pain relief, and a reduced severity of adverse effects.
This approach also facilitates early discharge, decreases cost, and helps prevent persistent postoperative pain.
It follows a step-down approach, as pain decreases over time, ensuring there is no "analgesic gap."

What are the new treatment modalities for opioids?

While opioids remain a mainstay, innovations focus on new delivery systems to provide non-invasive options. These include:

Oral Transmucosal Fentanyl (Fentanyl lollipop): For premedication and breakthrough pain.
Intranasal Fentanyl/Ketamine: For rapid, non-invasive pain management.
Intranasal Buprenorphine: Used in acute orthopedic trauma.
Patient-Controlled Transdermal Analgesia (Iontophoresis): A needle-free system using low-intensity electrical field to deliver fentanyl.
Sublingual Sufentanil (Zalviso): A pre-programmed, non-invasive device for patient-controlled analgesia.
Transdermal Therapeutic System (Fentanyl, Buprenorphine patches): For stable plasma concentrations, now used for long-term post-op pain after discharge (e.g., TKR, thoracotomy).
DepoDur (Extended-release epidural morphine): A single-dose liposomal morphine that provides up to 48 hours of analgesia.

What are the key non-opioid adjuncts in multimodal analgesia?

Adjuncts enhance opioid effects, providing an "opioid-sparing" effect and better pain relief with fewer side effects.

Paracetamol (IV, 2010): An established component with a ~40% opioid-sparing effect and a negligible side-effect profile, making it the safest drug.
NSAIDs (IV, patches): Provide superior analgesia and anti-inflammatory effects with an opioid-sparing effect.
Ketamine (Low-dose): Prevents persistent pain and opioid-induced hyperalgesia/tolerance. It decreases pro-inflammatory cytokines.
Dexmedetomidine: A highly selective alpha-2 agonist providing analgesia, sedation, and anxiolysis with minimal respiratory depression.
Gabapentinoids (Gabapentin/Pregabalin): Reduce postoperative pain, opioid use, and anxiety, especially where nerve damage is likely.
Magnesium: An NMDA receptor antagonist that prevents central sensitization.
Lidocaine (IV): A membrane stabilizer, beneficial in abdominal surgery.
Capsaicin: A TRPV1 agonist that decreases activation of C-fibers.

What is the current status of regional anesthesia techniques?

Epidural analgesia, while effective, is no longer the sole "gold standard."
Peripheral nerve blocks (PNBs) are now recommended as the first choice for many orthopedic procedures (e.g., hip/knee replacement).
They are effective and avoid side effects like hypotension.
Wound infiltration and local infiltration analgesia (LIA) are growing, especially in orthopedics.
The use of liposomal bupivacaine for single-injection blocks provides analgesia for up to 72 hours.
Continuous peripheral nerve blocks via catheters extend analgesia beyond a finite period.

What is the role of guidelines and acute pain services (APS)?

Guidelines from various societies (ASA, ASRA, ISA) strongly recommend multimodal analgesia,
surgical site-specific peripheral regional techniques, and neuraxial blocks for major surgeries.
The development of an Acute Pain Service (APS) is crucial for better organization,
application of existing knowledge, training, and clinical research to improve postoperative pain control.

What does the future hold for postoperative pain management?

The future points towards:

Procedure-specific pain management: Moving away from a "one-size-fits-all" approach.
Enhanced Recovery After Surgery (ERAS) protocols: Integrating analgesia with early nutrition and mobilization.
Genetically-informed, personalized medicine: Tailoring pain management based on genetic susceptibility.

Part 3: Ultrasound-Guided Regional Anesthesia in Acute Postoperative Pain (Dr. Puneet Mishra)

Why use ultrasound guidance for regional anesthesia?

The rationale for using ultrasound guidance is to decrease opioid dependence, hasten recovery, and minimize hospital resource utilization.
It has shortened the learning curve for regional anesthesia,
making it a reliable part of multimodal analgesia to decrease intraoperative opioid requirements and ease postoperative pain management.
Ultrasound has helped us better understand anatomy and functional utility of blocks, leading to safer and more effective techniques.

What are the benefits of regional anesthesia beyond acute pain relief?

Regional anesthesia benefits go beyond acute pain relief to improve overall patient outcomes,
reduce hospital resource utilization, and provide economic benefits.
It can also have positive effects on cancer recurrence and preventing persistent postoperative pain.

How are regional anesthesia techniques tailored for specific surgeries?

The 2016 American Pain Society guidelines recommend site-specific regional anesthesia techniques.

Thoracotomy: Paravertebral blocks are the first choice, evolving to erector spinae plane (ESP) blocks to stay away from the pleura and central neuraxis.
Open Liver Resection: Transversus Abdominis Plane (TAP) block, evolving to Quadratus Lumborum (QL) block.
Hip/Knee Replacement: Femoral nerve block, adductor canal block (spares motor function for early ambulation), and fascia iliaca compartment block.
Cesarean Section: TAP block, evolving to QL block.
Spine Fusion/Kyphoplasty: Paraspinal/erector spinae blocks to block the dorsal rami.

Can you give examples of upper limb blocks with ultrasound?

Superficial Cervical Plexus Block: For chemoport insertion, clavicular trauma, or thyroid surgery. The target is behind the posterior margin of the sternocleidomastoid muscle.
Interscalene Block: For upper arm and clavicular surgery. The target is the trunks between the anterior and middle scalene muscles. Using ultrasound, the volume of local anesthetic can be reduced to 5 mL, decreasing the chance of phrenic nerve block.
Infraclavicular Block: For elbow and forearm surgery. The target is the cords around the axillary artery. It is ideal for continuous catheter placement.
Rescue Blocks: Individual nerves (e.g., median nerve at the elbow) can be blocked for specific procedures or to supplement a patchy block.

Can you give examples of lower limb blocks with ultrasound?

Femoral Nerve Block: For femur surgery, cartilage repair, or hip analgesia. It is especially useful for positioning hip fracture patients for spinal anesthesia.
Fascia Iliaca Block: An extension of the femoral block, also covering the lateral femoral cutaneous nerve for lateral thigh coverage.
Adductor Canal Block: For knee surgery where motor-sparing analgesia is desired. It should be performed as distally as possible to spare the nerve to vastus medialis.
Sciatic Nerve Block: Can be performed at gluteal, subgluteal, or popliteal levels. The popliteal approach is excellent for continuous catheter placement for below-knee surgeries, such as diabetic foot debridement.

What are facial plane blocks and why are they important?

Facial plane blocks are newer options that have expanded regional anesthesia techniques.

PECS Block: For breast surgeries. PECS I targets the plane between pectoralis major and minor. PECS II targets the plane between pectoralis minor and serratus anterior, covering the axilla and lateral chest.
TAP Block: For abdominal wall analgesia. Approaches can be subcostal (for upper abdominal surgery) or posterior (for loin surgery).
Erector Spinae Plane (ESP) Block: For thoracic analgesia. The target is below the erector spinae muscle on top of the transverse process. It avoids the pleura and central neuraxis.
Quadratus Lumborum (QL) Block: For Cesarean sections, hip surgeries, or when neuraxial techniques are contraindicated. The target is the plane between the QL and psoas major muscles for maximum spread.
Thoracic Paravertebral Block: Effective for thoracic surgeries with less hypotension compared to epidurals and a good site for catheter insertion.

How can ultrasound help with neuraxial blocks?

Ultrasound can be used for "scout scanning" in patients with difficult spines.

Transverse view: Identifies the spinous process, transverse processes, and the posterior complex.
Parasagittal oblique view: Identifies the articular processes and facet joints.

For caudal blocks in children, a linear probe can be used transversely over the sacral hiatus to identify the sacral cornua and sacrococcygeal ligament,
ensuring the needle is in the correct plane and visualizing drug spread.

How can the duration of peripheral nerve blocks be extended?

The limited duration of single-shot blocks (6-8 hours) can be extended by:

Continuous Catheters: Placing a catheter for continuous infusion of local anesthetic.
Adjuncts: Drugs like dexamethasone (1-4 mg) can provide around 8 hours of additional block duration with minimal neural toxicity. Dexmedetomidine can be used but may cause hypotension or bradycardia. Buprenorphine can provide up to 9 hours but has side effects like nausea and vomiting.

What are the "thumb rules" for practicing regional anesthesia?

Know the anatomy and plan the block tailored to the patient's needs, considering the risk-benefit ratio.
Involve the patient in decision-making.
Follow up on the patient beyond the recovery room to identify any unanticipated complications.
Ensure proper labeling and color-coding of continuous infusion lines to prevent accidental intravascular injection.

Part 4: Panel Discussion and Q&A

Why is multimodal analgesia used instead of a single drug, given the modest evidence?

Dr. Pradeep Jain: Using a single drug in large quantities increases the risk of side effects, as no drug except paracetamol is free from them.
The concept is to use multiple drugs with different mechanisms in smaller quantities to achieve a summative or synergistic effect (1+1=11) for superior analgesia.
Dr. Ashok Kumar: Dr. Narendra Raij's systematic review suggests the evidence for multimodal analgesia can be disappointing and overrated, with the 24-hour morphine-sparing effect of individual non-opioids being modest.
However, this is due to the large number of variables in postoperative outcomes.
Current guidelines from major societies still strongly recommend it as the gold standard.

Are combinations of two non-opioids (e.g., Paracetamol + NSAID) effective?

The benefits of combining paracetamol and NSAIDs are "rather modest," and the benefits of combining other non-opioids may be overrated.
There is a lack of meta-analyses on combinations of different non-opioids, making it difficult to prove consistent success.

What is the mechanism of a continuous perineural infusion?

Dr. Puneet Mishra: The mechanism is to maintain a constant concentration of the local anesthetic at the specific target site (the nerve),
thereby providing a continuous block of impulse transmission and ongoing pain relief.

What are some promising future trends in pain management?

Needle-free techniques: Development of improved transdermal PCA systems.
Single-injection, long-acting drugs: Products like liposomal bupivacaine and DepoDur (extended-release epidural morphine).
Sublingual tablets: Sufentanil sublingual tablets (e.g., Zalviso) for post-surgical pain.
New drug classes: G-protein biased mu-opioid receptor ligands (e.g., Oliceridine/TRV130) in phase III trials.
Non-pharmacological methods: Complementary and alternative medicine therapies like cognitive behavioral therapy, TENS, and mindfulness-based stress reduction as adjuncts, though evidence is still lacking.